Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician?
The article discusses the results of randomized controlled trials and some observational studies that define the current understanding of the role of rivaroxaban in the prevention of cardioembolic complications in patients with atrial fibrillation (AF). According to the results of the randomized con...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2025-08-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/3202 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|